Literature DB >> 19188759

Melanocytes: from morphology to application.

A Santiago-Walker1, L Li, N K Haass, M Herlyn.   

Abstract

Melanocytes in human skin are intricately regulated by keratinocytes and the surrounding stroma. The development of melanoma is thought to arise from disrupted melanocyte homeostasis. It is now known that microenvironment plays a major role in maintenance of cellular homeostasis and can contribute to tumor initiation and tumor progression. Historically, melanocyte studies have been performed in two-dimensional culture systems, and often with melanocytes cultured in the absence of keratinocytes. Here we present the biological basis for the use of organotypic, three-dimensional model systems in the study of melanoma, and highlight the features of the most utilized organotypic model systems. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19188759     DOI: 10.1159/000178870

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  18 in total

1.  New procedure for epidermal cell isolation using kiwi fruit actinidin, and improved culture of melanocytes in the presence of leukaemia inhibitory factor and forskolin.

Authors:  Reza Yarani; Kamran Mansouri; Hamid Reza Mohammadi-Motlagh; Mitra Bakhtiari; Ali Mostafaie
Journal:  Cell Prolif       Date:  2013-05-10       Impact factor: 6.831

2.  Nano-characterization of two closely related melanoma cell lines with different metastatic potential.

Authors:  Justyna Gostek; Szymon Prauzner-Bechcicki; Benedikt Nimmervoll; Katrin Mayr; Joanna Pabijan; Peter Hinterdorfer; Lilia A Chtcheglova; Małgorzata Lekka
Journal:  Eur Biophys J       Date:  2014-12-04       Impact factor: 1.733

3.  Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?

Authors:  Nikolas K Haass
Journal:  Melanoma Manag       Date:  2015-05-18

4.  Particulate mediators of the bystander effect linked to suicide and interferon-β transgene expression in melanoma cells.

Authors:  Lucrecia Agnetti; Chiara Fondello; María Florencia Arbe; Gerardo C Glikin; Liliana M E Finocchiaro
Journal:  Gene Ther       Date:  2020-03-03       Impact factor: 5.250

Review 5.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

6.  Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment.

Authors:  Nikolas K Haass; D Ripperger; E Wladykowski; P Dawson; P A Gimotty; C Blome; F Fischer; P Schmage; I Moll; Johanna M Brandner
Journal:  Histochem Cell Biol       Date:  2009-10-21       Impact factor: 4.304

Review 7.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy.

Authors:  Camilla Pellegrini; Alessandra Zulian; Francesca Gualandi; Elisa Manzati; Luciano Merlini; Maria E Michelini; Luisa Benassi; Sandra Marmiroli; Alessandra Ferlini; Patrizia Sabatelli; Paolo Bernardi; Nadir M Maraldi
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

9.  Melanocytes from Patients Affected by Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy have Dysfunctional Mitochondria That Can be Rescued with Cyclophilin Inhibitors.

Authors:  Alessandra Zulian; Francesca Tagliavini; Erika Rizzo; Camilla Pellegrini; Francesca Sardone; Nicoletta Zini; Nadir Mario Maraldi; Spartaco Santi; Cesare Faldini; Luciano Merlini; Valeria Petronilli; Paolo Bernardi; Patrizia Sabatelli
Journal:  Front Aging Neurosci       Date:  2014-11-20       Impact factor: 5.750

Review 10.  Modeling Melanoma In Vitro and In Vivo.

Authors:  Kimberley A Beaumont; Nethia Mohana-Kumaran; Nikolas K Haass
Journal:  Healthcare (Basel)       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.